Just days after drug giant Pfizer announced that it would lay off several hundred scientists, there are rumors that the company may also make deep cut in its sales force. WNPR's Harriet Jones reports.
Pfizer won’t yet comment on the report, but the Wall Street Journal says according to its sources, the company is preparing to lay off as many as 2,400 people, amounting to a third of its sales force. Earlier this week it announced that as many as 800 jobs would go in its research and development arm, and it appears that the brunt of those cuts may fall in Connecticut.
Layoffs at its Groton New London facilities have been underway since Tuesday, and could affect 500 jobs there. John Markowicz, director of the Southeastern Connecticut Enterprise Region says many other jobs in the area depend on spending by Pfizer employees, and the ripple effect could be significant.
"The overall impact if the actual downsizing at Pfizer is between four and five hundred could be in 1,500 to 2000 range, the overall impact therefore on the unemployment rate could be a lot more significant than just what we’re thinking about now with respect to the direct terminations at the Pfizer facility."
The company has been undergoing an aggressive reorganization in recent years as it faces the loss of patent protection on some of its best selling medicines.